Home › NDC Lookup › Ingredients › Cadmium Sulphuratum, Carbo Animalis, Pho... › 82509-0001-60
encer Cadmium sulphuratum, Carbo animalis, Phosphoricum acidum, Radium bromatum, X-ray 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 6 [hp_C]/1 Tablet, Orally Disintegrating — NDC 82509-0001-60 package photo

encer Cadmium sulphuratum, Carbo animalis, Phosphoricum acidum, Radium bromatum, X-ray 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 6 [hp_C]/1 Tablet, Orally Disintegrating

by B'OKCARES LTD · 3 BLISTER PACK in 1 CARTON (82509-001-60) / 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
NDC 82509-0001-60
🏷️ FDA NDC (as labeled) 82509-001-60 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 82509-001-60
Product NDC 82509-001
11-digit billing NDC 82509000160
UNII 057EZR4Z7Q, 279O8I0433, E4GA8884NN, R74O7T8569, 6PRJ93602P
SPL Set ID 5d7bce73-077c-41c5-9b6b-8580dc79dc40
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-05-22
Route ORAL
Dosage form TABLET, ORALLY DISINTEGRATING
Substance CADMIUM SULFIDE; CARBO ANIMALIS; PHOSPHORIC ACID; RADIUM BROMIDE; ALCOHOL, X-RAY EXPOSED (1000 RAD)
Why two NDCs? The FDA registers this code as 82509-001-60 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 82509-0001-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerB'OKCARES LTD
Labeler code82509
First marketedMay 2023
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an unapproved homeopathic oral tablet that dissolves in the mouth. It contains cadmium sulfide, carbo animalis (animal charcoal), phosphoric acid, radium bromide, and alcohol exposed to x-rays, all in homeopathic dilutions. These ingredients are used in homeopathic practice according to traditional principles, though homeopathic products are not evaluated by the FDA for effectiveness or safety. Homeopathic use is based on historical tradition rather than established medical evidence.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white
ShapeRound
ImprintRinged;Cross;Symbol;on;1;Side
Size1 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII C151H8M554
    A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.

3 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesMagnesium stearate, maltodextrin, sucrose.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
encer 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 6 [hp_C]this 82509-0001-60 B'OKCARES 20 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2023
On the market since
May 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
82509-0001-60 You're viewing this 3 BLISTER PACK in 1 CARTON (82509-001-60) / 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 2023-05-22 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

encer Cadmium sulphuratum, Carbo animalis, Phosphoricum acidum, Radium bromatum, X-ray 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 30 [hp_C]/1; 6 [hp_C]/1 TABLET, ORALLY DISINTEGRATING is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 82509-001-60, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 82509-0001-60, written without dashes as 82509000160. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 82509-0001-60, the first segment (82509) is the labeler code FDA assigned to B'OKCARES LTD; the middle segment (0001) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (60) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by B'OKCARES LTD. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
B'OKCARES LTD is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 12 words ▾

Uses Temporarily relieves symptoms of fatigue caused by radiation and\ or radiotherapy.

⏱️ Dosage and Administration 77 words ▾

Directions Chew one tablet and allow to dissolve in the mouth for 1 minute before swallowing. Repeat 6 hours after the first dose. Must not be taken 10 minutes before or after eating. • Must not be taken within 6 hours of bedtime. • Do not exceed usage directions. May be taken during radiotherapy and for 12 weeks after the end of radiation treatment. Use may be continued for as long as fatigue related to radiation lasts.

⚠️ Warnings 86 words ▾

Warnings Warnings When using this product over-arousal, restlessness, or difficulty falling asleep may occur. Reduce use to one dose in the morning if this occurs. Stop use and ask doctor if condition worsens there is no improvement Ask a doctor before use if you are taking a prescription drug or have a serious medical condition.

If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 15 words ▾

Other information • Do not use if blister is broken. • Store at room temperature.

🧪 Active Ingredient 42 words ▾

Active Ingredients Cadmium sulphuratum 30C HPUS* Carbo animalis 30C HPUS* Phosphoricum acidum 30C HPUS* Radium bromatum 30C HPUS* X-Ray 6C HPUS* * The letters "HPUS" indicate the components in the product are officially monographed in the Homeopathic Pharmacopoeia of the Unites States.

🧪 Inactive Ingredients 6 words ▾

Inactive ingredients Magnesium stearate, maltodextrin, sucrose.

🎯 Purpose 72 words ▾

Purpose Cadmium sulphuratum 30C HPUS* .... Relieves fatigue symptoms Carbo animalis 30C HPUS* .... Relieves fatigue symptoms Phosphoricum acidum 30C HPUS* .... For poor concentration Radium bromatum 30C HPUS* .... Relieves radiation fatigue X-Ray 6C HPUS* .... Relieves radiation fatigue * The letters "HPUS" indicate the components in the product are officially monographed in the Homeopathic Pharmacopoeia of the Unites States.

Temporarily relieves symptoms of fatigue cause by radiation and\ or radiotherapy.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 82507-0004-01 · AGC 82510-0296-02 · Wander →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.